Search Results

Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225

• Authors : Meyer, Catherine; Prasad, Vikas; Stuparu, Andreea

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

• Source: EJNMMI Research. 12(1)

Record details

Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method.

• Authors : Iannone, Marco Nicola¹ (AUTHOR) ; Valtorta, Silvia^2,3,4 (AUTHOR); Stucchi, Stefano⁵ (AUTHOR)

• Source: EJNMMI Radiopharmacy & Chemistry. 6/21/2024, Vol. 9 Issue 1, p1-30. 30p.

Record details

Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?

• Authors : Taş, Harun¹ (AUTHOR) ; Bakos, Gábor¹ (AUTHOR) ; Bauder-Wüst, Ulrike¹ (AUTHOR)

• Source: Pharmaceuticals (14248247). Apr2024, Vol. 17 Issue 4, p513. 14p.

Record details

Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225

• Authors : Catherine Meyer; Vikas Prasad; Andreea Stuparu

Subjects: PSMA-TO-1; PSMA-617; Prostate cancer

• Source: EJNMMI Research, Vol 12, Iss 1, Pp 1-11 (2022)

Record details

89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man.

• Authors : Privé, Bastiaan M.¹ ; Derks, Yvonne H. W.¹; Rosar, Florian²

• Source: European Journal of Nuclear Medicine & Molecular Imaging. May2022, Vol. 49 Issue 6, p2064-2076. 13p. 2 Color Photographs, 1 Diagram, 1 Chart, 2 Graphs.

Record details

Synthesis and automated fluorine‐18 radiolabeling of new PSMA‐617 derivatives with a CuAAC radiosynthetic approach.

• Authors : Iannone, Marco N.¹ (AUTHOR) ; Stucchi, Stefano¹ (AUTHOR); Turolla, Elia A.¹ (AUTHOR)

• Source: Journal of Labelled Compounds & Radiopharmaceuticals. Mar2022, Vol. 65 Issue 3, p48-62. 15p.

Record details

Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617

• Authors : José Carlos dos Santos; Martin Schäfer; Ulrike Bauder-Wüst

Subjects: PSMA; prostate cancer; PET imaging

• Source: Frontiers in Chemistry, Vol 10 (2022)

Record details

Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

• Authors : Tim Wollenweber; Lucia Zisser; Elisabeth Kretschmer-Chott

Subjects: PSMA; prostate cancer; mCRPC

• Source: Current Oncology, Vol 28, Iss 5, Pp 3692-3704 (2021)

Record details

Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer

• Authors : Cordula A. Jilg; Kathrin Reichel; Christian Stoykow

Subjects: Radio-guided surgery; [111In]PSMA; Lymphadenectomy

• Source: EJNMMI Research, Vol 10, Iss 1, Pp 1-13 (2020)

Record details

Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617.

• Authors : Ferdinandus, Justin^1,2 (AUTHOR); Violet, John³ (AUTHOR); Sandhu, Shahneen^4,5 (AUTHOR)

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Sep2020, Vol. 47 Issue 10, p2322-2327. 6p. 1 Diagram, 1 Chart, 2 Graphs.

Record details